This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mark's Most Recent Article

The Run-Up Trade: Biodel's Insulin Trial Results

05/30/13 - 08:00 AM EDT

Biodel shares should move higher ahead of insulin trial results in the third quarter.

read more >

Other Articles by Mark

Free Reports

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

11/20/12 - 08:03 AM EST

Alexza expects US and European regulators to announce approval decisions in December.

read more >
Celsion: Run-Up Trade Into Thermodox Results

11/14/12 - 07:01 AM EST

Traders are already bidding up shares of Celsion in anticipation of pivotal trial results.

read more >
Short Trade: Supernus IPO Lock-Up

10/31/12 - 07:00 AM EDT

Supernus share should fall now that 10 million shares under lock-up can now be sold.

read more >
How to Prep for the Inevitable Bursting of the Biotech Stock Bubble

10/17/12 - 07:00 AM EDT

Traders need to be less cocky and more prepared for when stocks fall.

read more >
AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades

10/09/12 - 07:05 AM EDT

The biotech bull market has created a new category of swing trade catalysts.

read more >
How to Trade Hemispherx Even If You Hate the Stock

10/02/12 - 10:48 AM EDT

Biotech swing trader Mark Messier warns to look at Hemispherx as a short-term trade, not an investment.

read more >
Zogenix: Three Shots At Run-Up Trade

09/26/12 - 08:00 AM EDT

Get in Zogenix early before other traders start speculating over its chronic pain drug Zohydro.

read more >
Acadia Pharma, Sarepta Therapeutics: How to Trade Into Trial Results

09/19/12 - 07:31 AM EDT

Biotech trader Mark Messier explains how to position trades ahead of two important biotech clinical trials.

read more >
Dynavax: The BioRunUp Trade Into An FDA Panel

09/11/12 - 11:34 AM EDT

Biotech trader Mark Messier explains how to swing trade Dynavax into a Nov. 14 FDA advisory panel.

read more >
Page 2 of 2
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs